This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1986:45:11-20.

The myelodysplastic syndromes. Part I. What are they? Part II. Classification

PMID: 3515515

Review

The myelodysplastic syndromes. Part I. What are they? Part II. Classification

D A Galton. Scand J Haematol Suppl. 1986.

. 1986:45:11-20.

Author

PMID: 3515515

No abstract available

PubMed Disclaimer

Similar articles

[The myelodysplastic syndrome based on our cases].
Bozóky G, Farkas L, Serényi P, Biliczki F. Bozóky G, et al. Orv Hetil. 1986 Aug 17;127(33):1993-8. Orv Hetil. 1986. PMID: 3466134 Hungarian. No abstract available.
Classification of the myelodysplastic syndromes.
Bennett JM. Bennett JM. Clin Haematol. 1986 Nov;15(4):909-23. Clin Haematol. 1986. PMID: 3471370 No abstract available.
Myelodysplastic syndromes: natural history and features of prognostic importance.
Mufti GJ, Galton DA. Mufti GJ, et al. Clin Haematol. 1986 Nov;15(4):953-71. Clin Haematol. 1986. PMID: 3552350 Review. No abstract available.
[Myelodysplastic syndromes].
Sainty D, Horschowski N, Fossat C, Sampol J. Sainty D, et al. Ann Biol Clin (Paris). 1985;43(6):821-30. Ann Biol Clin (Paris). 1985. PMID: 3914223 Review. French. No abstract available.
Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ. Oscier DG, et al. Leuk Res. 1989;13(9):833-9. doi: 10.1016/0145-2126(89)90097-0. Leuk Res. 1989. PMID: 2796388

See all similar articles

Cited by

Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.
Verhoef GE, De Wolf-Peeters C, Ferrant A, Deprez S, Meeus P, Stul M, Zacheé P, Cassiman JJ, Van den Berghe H, Boogaerts MA. Verhoef GE, et al. Ann Hematol. 1991 Nov;63(5):235-41. doi: 10.1007/BF01698371. Ann Hematol. 1991. PMID: 1958747
Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes.
De Sanctis G, Bottari V, Frezzolini A, Ficcardi M, De Rossi G, Petti MC, Mandelli F, Fontana L. De Sanctis G, et al. Cancer Immunol Immunother. 1992;34(6):414-8. doi: 10.1007/BF01741753. Cancer Immunol Immunother. 1992. PMID: 1563019 Free PMC article.
Primary myelodysplastic syndrome and cancer.
Clark RE, Payne HE, Jacobs A, West RR. Clark RE, et al. Br Med J (Clin Res Ed). 1987 Apr 11;294(6577):937-8. doi: 10.1136/bmj.294.6577.937-a. Br Med J (Clin Res Ed). 1987. PMID: 3107665 Free PMC article. No abstract available.
A strategy for erythropoietin treatment in myelodysplastic syndromes.
Hast R. Hast R. Med Oncol. 1999 Sep;16(3):188-90. doi: 10.1007/BF02906130. Med Oncol. 1999. PMID: 10523798 Review. No abstract available.
Plasma cyclic nucleotide levels in patients with refractory anaemia with excess of blasts.
Peracchi M, Bamonti-Catena F, Bareggi B, Calori R, Maiolo AT. Peracchi M, et al. Blut. 1990 Mar;60(3):177-80. doi: 10.1007/BF01720272. Blut. 1990. PMID: 2156584

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information